Bloomberg News

Testosterone Drugs May Boost Libidos, Drugmaker Profits

May 02, 2012

Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men who have low levels of testosterone. Doctors warn demand for the treatments could lead to overuse with deadly side effects. Bloomberg's Shannon Pettypiece reports. (Source: Bloomberg)

Running Time: 01:56


Too Cool for Crisis Management
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus